Merck

Diagonal Banks Another $125M for ‘Clustering’ Antibody Drugs

Merck Backs Off Revolution After Failing To Agree on Price: WSJ

Biopharma M&A Heats Up, Rare Diseases Win Three Approvals, Wave Crashes

AbbVie, Amgen, Lilly Lead Calls for FDA To Update Post-Approval Change Rules

Hims & Hers Expands Personalized Digital Healthcare Platform

How Merck Plans to Set a Buffer for Keytruda's Patent Cliff

FDA Lifts Partial Hold on Merck, Daiichi's Phase 3 Lung Cancer Study

Breast Cancer Treatments Heat Up: Six Therapies Poised to Transform Patient Outcomes

Healthtech, Biotech: Why the UK Is Emerging as an Essential Hub

Servier Signs €1bn-Plus AI Pact with Iktos

FDA Sets Feb. 1 Launch Date for PreCheck Pilot To Strengthen Domestic Supply Chain

Merck Splits Operations to Separate Oncology From Non-Cancer Drugs

‘Almost Like a Religion’: Pfizer CEO Slams RFK Jr.’s 'Anti-Science' Vaccine Policies

Flagship CEO Calls Out Attacks on Science, Warns of China Dominance

PharmaShots Quarterly Outlook: The Forces Reshaping Biopharma in Q1 2026

Permittivity Provides an In-Line Cell Health Early-Warning System

Frontier Medicines Grants Ex-China Rights of FMC-220 to LG Chem

Novo Launches Oral Obesity Pill, Lilly Targets Lofty Revenue, FDA and M&A in Focus

TotalEnergies Inks 1GW Google Solar Deal

IO Shuts Down Following Regulatory Roadblocks

The Top 10 PharmTech Videos of 2025

Peter Thiel’s Big Bet on Solar-Powered Cow Collars

Merck and Mayo Clinic Partner on AI-Driven Drug Research

Merck Receives the EC Approval for Keytruda, Plus CT ± Avastin to Treat PD-L1+ Pt-Resistant Ovarian Carcinoma

Why Owning the Learning Loop Matters More Than Owning the Lab

Merck to Acquire Terns Pharmaceuticals for $6.7 B, Accelerating M&A Ahead of Keytruda Patent Expiry

Proteasomes: A Novel Approach to Target the Immune System

STAT+: GSK Picks up Pulmonary Hypertension Drug with 35Pharma Acquisition

Report Says MSD Is in Talks to Buy Revolution Meds

Biotech’s Next Chapter: Asset-Centric Deals and Shifting Alpha at JPM 2026

GSK Joins Growing PD-1 SubQ Push With Alteogen Alliance Worth up to $285M+

An Analysis of International Space Station Experiments

Lilly Strikes Again, Buying CAR-T Firm Orna for $2.4bn

Synthesia Hits $4B Valuation, Lets Employees Cash Out

Solve Therapeutics Secures $120 Million

Advancing Pharmaceutical Quality Through Integrated Digital Systems and Collaborative Scientific Innovation

Haisco Steps Onto Global Stage with Blue Chip NewCo Deal

Valo Health CEO: We Don’t Want Investors To Drive the Science

Jim Cramer's Top 10 Things to Watch in the Stock Market Friday

FDA Policy Tracker 2026: Priority Vouchers Questioned, PRVs Return

FMC Raises €100M in Funding

Boehringer Signs €1bn+ Deal for Simcere IBD Candidate

2025 Novel Large Molecule FDA Drug Approvals

Lung Cancer Trial to Proceed After FDA Releases Hold on Merck, Daiichi’s ADC

Codexis Reports Fourth Quarter and Fiscal Year 2025 Financial Results

UK Tech Funding Drops 11% in 2025, but Late-Stage Capital Remains Resilient

Merck Initiates P-IIb/III (MALBEC) Trial of MK-8748 for Neovascular Age-Related Macular Degeneration

Behind the Headlines Episode 32: AI’s Power, NVIDIA & Lilly, Revolution Medicine

Peptonics Solves Cell Culture Defoaming Debacle

Pharmaceutical Executive Daily: FDA Issues Warning Letter to ImmunityBio

Merck to Acquire Cidara Therapeutics to Advance Universal Flu Vaccine

Merck Exercises Option to License Evaxion's EVX‑B3 Infectious Disease Vaccine Candidate

Solve Therapeutics Raises $120M in Oversubscribed Funding Round

Merck to Acquire Terns Pharmaceuticals for $6.7B